Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer

Cancer statistics, 2019

Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377 · see citing works

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474 · see citing works

Colorectal cancer

Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 5,189 · see citing works

Colorectal cancer statistics, 2020

Siegel, R. L., Miller, K. D., Sauer, A. G., Fedewa, S. A., Butterly, L. F., Anderson, J. C., Cercek, A., Smith, R. A., & Jemal, A. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21601 · Cited by 4,970 · see citing works

A framework for advancing our understanding of cancer-associated fibroblasts

Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · see citing works

Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium

Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753 · see citing works

Organoid Models and Applications in Biomedical Research

Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000433566 · Cited by 3,517 · see citing works

Modeling Development and Disease with Organoids

Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · see citing works

Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies

Keum, N., & Giovannucci, E. L. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0189-8 · Cited by 2,690 · see citing works

Clinical development success rates for investigational drugs

Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536 · see citing works

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408 · see citing works

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160 · see citing works

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096 · see citing works

Organoids in cancer research

Drost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790 · see citing works

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

Hidalgo, M. M., Amant, F. C., Biankin, A. V., Budínská, E., Byrne, A. T., Caldas, C., Clarke, R. B., de Jong, S., Jonkers, J., Mælandsmo, G. M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0001 · Cited by 1,748 · see citing works

Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623 · see citing works

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Islami, F., Goding Sauer, A., Miller, K. D., Siegel, R. L., Fedewa, S. A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Ma, J., Soerjomataram, I., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21440 · Cited by 1,610 · see citing works

A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse

Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591 · see citing works

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559 · see citing works

Organoid modeling of the tumor immune microenvironment

Neal, J. T., Li, X., Zhu, J., Giangarra, V., Grzeskowiak, C. L., Ju, J., Liu, I. H., Chiou, S.-H., Salahudeen, A. A., Smith, A. R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.021 · Cited by 1,556 · see citing works

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393 · see citing works

Hereditary and Familial Colon Cancer

Jasperson, K. W., Tuohy, T. M. F., Neklason, D. W., & Burt, R. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.054 · Cited by 1,314 · see citing works

Patient-derived tumour xenografts as models for oncology drug development

Tentler, J. J., Tan, A. C., Weekes, C. D., Jimeno, A., Leong, S., Pitts, T. M., Arcaroli, J. J., Messersmith, W. A., & Eckhardt, S. G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.61 · Cited by 1,277 · see citing works

In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., Collins, N. B., Bi, K., LaFleur, M. W., Juneja, V. R., et al. (2017) · Nature · doi:10.1038/nature23270 · Cited by 1,147 · see citing works

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

Dijkstra, K. K., Cattaneo, C. M., Weeber, F., Chalabi, M., van de Haar, J., Fanchi, L. F., Slagter, M., van der Velden, D. L., Kaing, S., Kelderman, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.009 · Cited by 1,135 · see citing works

Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids

Matano, M., Date, S., Shimokawa, M., Takano, A., Fujii, M., Ohta, Y., Watanabe, T., Kanai, T., & Sato, T. (2015) · Nature Medicine · doi:10.1038/nm.3802 · Cited by 1,135 · see citing works

Sequential cancer mutations in cultured human intestinal stem cells

Drost, J., van Jaarsveld, R. H., Ponsioen, B., Zimberlin, C., van Boxtel, R., Buijs, A., Sachs, N., Overmeer, R. M., Offerhaus, G. J., Begthel, H., et al. (2015) · Nature · doi:10.1038/nature14415 · Cited by 1,067 · see citing works

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

Sartore-Bianchi, A., Trusolino, L., Martino, C., Bencardino, K., Lonardi, S., Bergamo, F., Zagonel, V., Leone, F., Depetris, I., Martinelli, E., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00150-9 · Cited by 1,016 · see citing works

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance

Marusyk, A., Janiszewska, M., & Polyak, K. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.007 · Cited by 1,009 · see citing works

Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis

Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 955 · see citing works

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

Pauli, C., Hopkins, B. D., Prandi, D., Shaw, R. C., Fedrizzi, T., Sboner, A., Sailer, V., Augello, M. A., Puca, L., Rosati, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1154 · Cited by 943 · see citing works

A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer

Bertotti, A., Migliardi, G., Galimi, F., Sassi, F., Torti, D., Isella, C., Corà, D., Di Nicolantonio, F., Buscarino, M., Petti, C., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0109 · Cited by 939 · see citing works

Genetic and transcriptional evolution alters cancer cell line drug response

Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C. A., Dempster, J., Lyons, N. J., Burns, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0409-3 · Cited by 931 · see citing works

A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis

Fujii, M., Shimokawa, M., Date, S., Takano, A., Matano, M., Nanki, K., Ohta, Y., Toshimitsu, K., Nakazato, Y., Kawasaki, K., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.003 · Cited by 852 · see citing works

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

Ooft, S. N., Weeber, F., Dijkstra, K. K., McLean, C. M., Kaing, S., van Werkhoven, E., Schipper, L., Hoes, L., Vis, D. J., van de Haar, J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay2574 · Cited by 813 · see citing works

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer

Yao, Y., Xu, X., Yang, L., Zhu, J., Wan, J., Shen, L., Xia, F., Fu, G., Deng, Y., Pan, M., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2019.10.010 · Cited by 755 · see citing works

Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer

Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752 · see citing works

Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer

Bardelli, A., & Siena, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6116 · Cited by 746 · see citing works

Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer

Kreso, A., O'Brien, C. A., van Galen, P., Gan, O. I., Notta, F., Brown, A. M. K., Ng, K., Ma, J., Wienholds, E., Dunant, C. F., et al. (2012) · Science · doi:10.1126/science.1227670 · Cited by 738 · see citing works

Patient-derived xenografts undergo mouse-specific tumor evolution

Ben-David, U., Ha, G., Tseng, Y.-Y., Greenwald, N. F., Oh, C., Shih, J., McFarland, J. M., Wong, B., Boehm, J. S., Beroukhim, R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3967 · Cited by 716 · see citing works

Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer

Kopetz, S., Desai, J., Chan, E., Hecht, J. R., O'Dwyer, P. J., Maru, D., Morris, V., Janku, F., Dasari, A., Chung, W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.2497 · Cited by 697 · see citing works

Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges

Day, C.-P., Merlino, G., & Van Dyke, T. (2015) · Cell · doi:10.1016/j.cell.2015.08.068 · Cited by 676 · see citing works

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Byrne, A. T., Alférez, D., Amant, F. C., Annibali, D., Arribas, J., Biankin, A. V., Bruna, A., Budínská, E., Caldas, C., Chang, D. K.-F., et al. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2016.140 · Cited by 663 · see citing works

Amplification of the <i>MET</i> Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Bardelli, A., Corso, S., Bertotti, A., Hobor, S., Valtorta, E., Siravegna, G., Sartore-Bianchi, A., Scala, E., Cassingena, A., Zecchin, D., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0558 · Cited by 657 · see citing works

Phase II and phase III failures: 2013–2015

Harrison, R. K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.184 · Cited by 636 · see citing works

An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer

Feins, S., Kong, W., Williams, E. F., Milone, M. C., & Fraietta, J. A. (2019) · American Journal of Hematology · doi:10.1002/ajh.25418 · Cited by 614 · see citing works

The Clinical Relevance of Cancer Cell Lines

Gillet, J.-P., Varma, S., & Gottesman, M. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt007 · Cited by 601 · see citing works

Drug resistance and new therapies in colorectal cancer

Jeught, K. V. D., Xu, H.-C., Li, Y.-J., Lu, X.-B., & Ji, G. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i34.3834 · Cited by 597 · see citing works

The Intestinal Microbiota and Colorectal Cancer

Cheng, Y., Ling, Z., & Li, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615056 · Cited by 588 · see citing works

Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution

Eirew, P. D., Steif, A., Khattra, J. S., Ha, G., Yap, D., Farahani, H., Gelmon, K. A., Chia, S., Mar, C., Wan, A. N. C., et al. (2014) · Nature · doi:10.1038/nature13952 · Cited by 585 · see citing works

The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies

Fazio, V. M., Robertis, M. D., Massi, E., Poeta, M. L., Carotti, S., Morini, S., Cecchetelli, L., & Signori, E. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.78279 · Cited by 583 · see citing works

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

Meric-Bernstam, F., Hurwitz, H., Raghav, K. P. S., McWilliams, R. R., Fakih, M., VanderWalde, A., Swanton, C., Kurzrock, R., Burris, H., Sweeney, C., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30904-5 · Cited by 573 · see citing works

A rectal cancer organoid platform to study individual responses to chemoradiation

Ganesh, K., Wu, C., O’Rourke, K. P., Szeglin, B. C., Zheng, Y., Sauvé, C.-E. G., Adileh, M., Wasserman, I., Marco, M. R., Kim, A. S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0584-2 · Cited by 569 · see citing works

Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture Condition

Fujii, M., Matano, M., Toshimitsu, K., Takano, A., Mikami, Y., Nishikori, S., Sugimoto, S., & Sato, T. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.11.016 · Cited by 558 · see citing works

Tumorigenesis: it takes a village

Tabassum, D. P., & Polyák, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3971 · Cited by 558 · see citing works

Intra-tumour diversification in colorectal cancer at the single-cell level

Roerink, S. F., Sasaki, N., Lee-Six, H., Young, M. D., Alexandrov, L. B., Behjati, S., Mitchell, T. J., Großmann, S., Lightfoot, H. W., Egan, D. A., et al. (2018) · Nature · doi:10.1038/s41586-018-0024-3 · Cited by 554 · see citing works

Cancer-associated fibroblasts and tumor growth – bystanders turning into key players

Östman, A., & Augsten, M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.003 · Cited by 542 · see citing works

Untitled work

(2003) · PubMed · Cited by 523 · see citing works

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in <i>BRAF</i> V600–Mutant Colorectal Cancer

Corcoran, R. B., Atreya, C. E., Falchook, G. S., Kwak, E. L., Ryan, D. P., Bendell, J. C., Hamid, O., Messersmith, W. A., Daud, A., Kurzrock, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.2471 · Cited by 507 · see citing works

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer.

Amodio, V., Yaeger, R., Arcella, P., Cancelliere, C., Lamba, S., Lorenzato, A., Arena, S., Montone, M., Mussolin, B., Bian, Y., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0187 · Cited by 504 · see citing works

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

Zhang, X., Claerhout, S., Prat, A., Dobrolecki, L. E., Petrovic, I., Lai, Q., Landis, M. D., Wiechmann, L., Schiff, R., Giuliano, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4081 · Cited by 483 · see citing works

Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases

Weeber, F., van de Wetering, M., Hoogstraat, M., Dijkstra, K. K., Krijgsman, O., Kuilman, T., Gadellaa-van Hooijdonk, C. G. M., van der Velden, D. L., Peeper, D. S., Cuppen, E. P. J. G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516689112 · Cited by 482 · see citing works

The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer

Bertotti, A., Papp, E., Jones, S., Adleff, V., Anagnostou, V., Lupo, B., Sausen, M., Phallen, J., Hruban, C. A., Tokheim, C., et al. (2015) · Nature · doi:10.1038/nature14969 · Cited by 479 · see citing works

High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping

Czerniecki, S. M., Cruz, N. M., Harder, J. L., Menon, R., Annis, J., Otto, E. A., Gulieva, R. E., Islas, L. V., Kim, Y. K., Tran, L. M., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.04.022 · Cited by 465 · see citing works

Genetic alterations in colorectal cancer.

Armaghany, T., Wilson, J. D., Chu, Q., & Mills, G. M. (2012) · Europe PMC (PubMed Central) · Cited by 438 · see citing works

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds

Bruna, A., Rueda, O. M., Greenwood, W., Batra, A. S., Callari, M., Batra, R. N., McNamara, K. L., Sandoval, J. L., Cassidy, J. W., Vidaković, A. T., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.041 · Cited by 432 · see citing works

Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts

Hoffman, R. M. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3972 · Cited by 424 · see citing works

A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer

Hidalgo, M. M., Bruckheimer, E. M., Rajeshkumar, N. V., Garrido‐Laguna, I., Oliveira, E. D., Rubio‐Viqueira, B., Strawn, S. J., Wick, M. J., Martell, J., & Sidransky, D. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0233 · Cited by 406 · see citing works

Xenograft and organoid model systems in cancer research

Bleijs, M., van de Wetering, M., Clevers, H., & Drost, J. (2019) · The EMBO Journal · doi:10.15252/embj.2019101654 · Cited by 400 · see citing works

Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex

King, M. A., Covassin, L., Brehm, M. A., Racki, W. J., Pearson, T., Leif, J., Laning, J. C., Fodor, W. L., Foreman, O., Burzenski, L. M., et al. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03933.x · Cited by 389 · see citing works

Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice

Kim, M. P., Evans, D. B., Wang, H., Abbruzzese, J. L., Fleming, J. B., & Gallick, G. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.171 · Cited by 383 · see citing works

The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy

Xiao, Y., & Freeman, G. J. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1397 · Cited by 368 · see citing works

Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer

Julien-Grille, S., Merino‐Trigo, A., Lacroix, L., Pocard, M. D., Goèré, D., Mariani, P., Landron, S., Bigot, L., Némati, F., Dartigues, P., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0372 · Cited by 358 · see citing works

3D model for CAR‐mediated cytotoxicity using patient‐derived colorectal cancer organoids

Schnalzger, T. E., de Groot, M. H., Zhang, C., Mosa, M. H., Michels, B. E., Röder, J., Darvishi, T., Wels, W. S., & Farin, H. F. (2019) · The EMBO Journal · doi:10.15252/embj.2018100928 · Cited by 354 · see citing works

Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches

McQuade, R. M., Stojanovska, V., Bornstein, J. C., & Nurgali, K. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170111152436 · Cited by 351 · see citing works

Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts

Cassidy, J. W., Caldas, C., & Bruna, A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0727 · Cited by 346 · see citing works

Cancer Cell Lines Are Useful Model Systems for Medical Research

Mirabelli, P., Coppola, L., & Salvatore, M. (2019) · Cancers · doi:10.3390/cancers11081098 · Cited by 346 · see citing works

Examining the utility of patient-derived xenograft mouse models

Aparicio, S. A. J. R., Hidalgo, M. M., & Kung, A. L. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3944 · Cited by 345 · see citing works

Humanized mice in studying efficacy and mechanisms of PD‐1‐targeted cancer immunotherapy

Wang, M., Yao, L., Cheng, M., Cai, D., Martínek, J., Pan, C.-X., Shi, W., Ma, A., White, R. D., Airhart, S. D., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700740r · Cited by 338 · see citing works

5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation

Cho, Y., Ro, E. J., Yoon, J.-S., Mizutani, T., Kang, D.-W., Park, J., Kim, T. I., Clevers, H. C., & Choi, K. (2020) · Nature Communications · doi:10.1038/s41467-020-19173-2 · Cited by 338 · see citing works

The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response

Sánchez‐Alcoholado, L., Ramos‐Molina, B., Otero, A. P., Laborda-Illanes, A., Ordóñez, R., Medina, J. A., Gómez‐Millán, J., & Queipo‐Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12061406 · Cited by 338 · see citing works

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

Schütte, M., Risch, T., Abdavi-Azar, N., Boehnke, K., Schumacher, D., Keil, M., Yildirimman, R., Jandrasits, C., Borodina, T. A., Amstislavskiy, V. S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14262 · Cited by 333 · see citing works

Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer

Fumagalli, A., Oost, K. C., Kester, L. A., Morgner, J., Bornes, L., Bruens, L., Spaargaren, L., Azkanaz, M., Schelfhorst, T., Beerling, E., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.02.008 · Cited by 321 · see citing works

Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications

Sinicrope, F. A., & Sargent, D. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1469 · Cited by 312 · see citing works

Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts

Fior, R., Póvoa, V., Mendes, R. V., Carvalho, T., Gomes, A. P., Figueiredo, N., & Ferreira, M. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618389114 · Cited by 312 · see citing works

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

Majumder, B., Ulaganathan, B., Thiyagarajan, S., Radhakrishnan, P., Narasimhan, H., Dhandapani, M., Brijwani, N., Pinto, D. D., Prasath, A., Shanthappa, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms7169 · Cited by 307 · see citing works

Immunogenicity of CAR T cells in cancer therapy

Wagner, D. L., Fritsche, E., Pulsipher, M. A., Ahmed, N. M., Hamieh, M., Hegde, M. G., Ruella, M., Savoldo, B., Shah, N. N., Turtle, C. J., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00476-2 · Cited by 307 · see citing works

HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment

Kavuri, S. M., Jain, N., Galimi, F., Cottino, F., Leto, S. M., Migliardi, G., Searleman, A. C., Shen, W., Monsey, J., Trusolino, L., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1211 · Cited by 302 · see citing works

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

Medico, E., Russo, M., Picco, G., Cancelliere, C., Valtorta, E., Corti, G., Buscarino, M., Isella, C., Lamba, S., Martinoglio, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms8002 · Cited by 302 · see citing works

Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer

Isella, C., Brundu, F. G., Bellomo, S. E., Galimi, F., Zanella, E. R., Porporato, R., Petti, C., Fiori, A., Orzan, F., Senetta, R., et al. (2017) · Nature Communications · doi:10.1038/ncomms15107 · Cited by 298 · see citing works

Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche

Roulis, M., Kaklamanos, A., Schernthanner, M., Bielecki, P., Zhao, J., Kaffe, E., Frommelt, L.-S., Qu, R., Knapp, M. S., Henriques, A. R., et al. (2020) · Nature · doi:10.1038/s41586-020-2166-3 · Cited by 298 · see citing works

MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation

Sénard, T., Gargano, A., Falck, D., de Taeye, S. W., Rispens, T., Vidarsson, G., Wuhrer, M., Somsen, G. W., & Domínguez‐Vega, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02049 · Cited by 297 · see citing works

AOM/DSS Model of Colitis-Associated Cancer

Parang, B., Barrett, C. W., & Williams, C. S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3603-8_26 · Cited by 279 · see citing works

A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids

Phan, N., Hong, J. J., Tofig, B., Mapua, M., Elashoff, D., Moatamed, N. A., Huang, J., Memarzadeh, S., Damoiseaux, R., & Soragni, A. (2019) · Communications Biology · doi:10.1038/s42003-019-0305-x · Cited by 269 · see citing works

Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models

Okada, S., Vaeteewoottacharn, K., & Kariya, R. (2019) · Cells · doi:10.3390/cells8080889 · Cited by 264 · see citing works

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

Verissimo, C. S., Overmeer, R. M., Ponsioen, B., Drost, J., Mertens, S., Verlaan-Klink, I., Gerwen, B. V., van der Ven, M., Wetering, M. V. D., Egan, D. A., et al. (2016) · eLife · doi:10.7554/elife.18489 · Cited by 263 · see citing works

Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids

Fumagalli, A., Drost, J., Suijkerbuijk, S. J. E., van Boxtel, R., de Ligt, J., Offerhaus, G. J. A., Begthel, H., Beerling, E., Tan, E. H., Sansom, O. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701219114 · Cited by 259 · see citing works

Colorectal cancer consensus molecular subtypes translated to preclinical models uncover potentially targetable cancer cell dependencies

Sveen, A., Bruun, J., Eide, P. W., Eilertsen, I. A., Ramirez, L., Murumägi, A., Arjama, M., Danielsen, S. A., Kryeziu, K., Elez, E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1234 · Cited by 256 · see citing works

Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer

Siena, S., Bianchi, A. S., Marsoni, S., Hurwitz, H. I., McCall, S. J., Penault-Llorca, F. M., Srock, S., Bardelli, A., & Trusolino, L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy100 · Cited by 249 · see citing works

Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids

Bolhaqueiro, A. C. F., Ponsioen, B., Bakker, B., Klaasen, S. J., Küçükköse, E., van Jaarsveld, R. H., Vivié, J., Verlaan-Klink, I., Hami, N., Spierings, D. C. J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0399-6 · Cited by 240 · see citing works

Molecular targeted therapy of cancer: The progress and future prospect

Xing, K., & Shen, L. (2017) · Frontiers in Laboratory Medicine · doi:10.1016/j.flm.2017.06.001 · Cited by 234 · see citing works

Manipulation of the Innate Immune Response by Varicella Zoster Virus

Gerada, C., Campbell, T., Kennedy, J. J., Mcsharry, B. P., Steain, M., Slobedman, B., & Abendroth, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00001 · Cited by 234 · see citing works

Genomic evolution of cancer models: perils and opportunities

Ben‐David, U., Beroukhim, R., & Golub, T. R. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0095-3 · Cited by 220 · see citing works

Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients

Kong, J., Lee, H., Kim, D., Han, S. K., Ha, D., Shin, K., & Kim, S. (2020) · Nature Communications · doi:10.1038/s41467-020-19313-8 · Cited by 219 · see citing works

Creation of “Humanized” Mice to Study Human Immunity

Pearson, T., Greiner, D. L., & Shultz, L. D. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1521s81 · Cited by 214 · see citing works

Pathway-specific differences between tumor cell lines and normal and tumor tissue cells

Ertel, A., Verghese, A. I., Byers, S. W., Ochs, M. F., & Tözeren, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-55 · Cited by 213 · see citing works

Human Cancer Growth and Therapy in Immunodeficient Mouse ModelsPreprint

Shultz, L. D., Goodwin, N. C., Ishikawa, F., Hosur, V., Lyons, B. L., & Greiner, D. L. (2014) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top073585 · Cited by 211 · see citing works

Clinical Approval Success Rates for Investigational Cancer Drugs

DiMasi, J. A., Reichert, J. M., Feldman, L., & Malins, A. J. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.117 · Cited by 203 · see citing works

Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

Migliardi, G., Sassi, F., Torti, D., Galimi, F., Zanella, E. R., Buscarino, M., Ribero, D., Muratore, A., Massucco, P., Pisacane, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2683 · Cited by 191 · see citing works

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

PDXNET Consortium, Woo, X. Y., EurOPDX Consortium, Giordano, J., Srivastava, A., Zhao, Z.-M., Lloyd, M. W., de Bruijn, R., Suh, Y.-S., Patidar, R., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00750-6 · Cited by 190 · see citing works

Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy

Narasimhan, V., Wright, J. A., Churchill, M., Wang, T., Rosati, R., Lannagan, T. R. M., Vrbanac, L., Richardson, A. B., Kobayashi, H., Price, T. J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0073 · Cited by 188 · see citing works

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

Capasso, A., Lang, J., Pitts, T. M., Jordan, K. R., Lieu, C. H., Davis, S. L., Diamond, J. R., Kopetz, S., Barbee, J., Peterson, J. N., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0518-z · Cited by 178 · see citing works

Growth of human tumors in cortisone-treated laboratory animals: the possibility of obtaining permanently transplantable human tumors.

Toolan, H. W. (2003) · PubMed · Cited by 171 · see citing works

Hydrogel-based colorectal cancer organoid co-culture models

Luo, X., Fong, E. L. S., Zhu, C., Lin, Q. X. X., Xiong, M., Li, A., Li, T., Benoukraf, T., Yu, H., & Liu, S. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.037 · Cited by 171 · see citing works

Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases

Fujii, M., & Sato, T. (2020) · Nature Materials · doi:10.1038/s41563-020-0754-0 · Cited by 165 · see citing works

Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors

Némati, F., Sastre‐Garau, X., Laurent, C., Couturier, J., Mariani, P., Desjardins, L., Piperno-Neumann, S., Lantz, O. J., Asselain, B. J. R., Plancher, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3066 · Cited by 165 · see citing works

An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses

Meraz, I. M., Majidi, M., Meng, F., Shao, R., Ha, M. J., Neri, S., Fang, B., Lin, S. H., Tinkey, P. T., Shpall, E. J., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0874 · Cited by 161 · see citing works

LifeTime and improving European healthcare through cell-based interceptive medicine

Rajewsky, N., Almouzni, G., Gorski, S. A., Aerts, S., Amit, I., Bertero, M. G., Bock, C., Bredenoord, A. L., Cavalli, G., Chiocca, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2715-9 · Cited by 156 · see citing works

Medicine in the United States

(2015) · Routledge eBooks · doi:10.4324/9781315727493-3 · Cited by 153 · see citing works

Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer

Cristobal, A., van den Toorn, H., van de Wetering, M., Clevers, H. C., Heck, A. J. R., & Mohammed, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.016 · Cited by 152 · see citing works

Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine

Praharaj, P. P., Bhutia, S. K., Nagrath, S., Bitting, R. L., & Deep, G. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.005 · Cited by 147 · see citing works

In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer

Carugo, A., Genovese, G., Seth, S., Nezi, L., Rose, J. L., Bossi, D., Cicalese, A., Shah, P. K., Viale, A., Pettazzoni, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.063 · Cited by 145 · see citing works

Genetic and epigenetic alterations of colorectal cancer

Hong, S. N. (2018) · Intestinal Research · doi:10.5217/ir.2018.16.3.327 · Cited by 144 · see citing works

Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment

Yamauchi, T., Takenaka, K., Urata, S., Shima, T., Kikushige, Y., Tokuyama, T., Iwamoto, C., Nishihara, M., Iwasaki, H., Miyamoto, T., et al. (2013) · Blood · doi:10.1182/blood-2012-06-440354 · Cited by 143 · see citing works

Modeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids

Fujii, M., Clevers, H. C., & Sato, T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.048 · Cited by 140 · see citing works

PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models

Meehan, T. F., Conte, N., Goldstein, T. C., Inghirami, G., Murakami, M. A., Brabetz, S., Gu, Z., Wiser, J. A., Dunn, P. J., Begley, D. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0582 · Cited by 134 · see citing works

Tumor organoid models in precision medicine and investigating cancer-stromal interactions

Xu, R., Zhou, X., Wang, S., & Trinkle, C. (2021) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2020.107668 · Cited by 134 · see citing works

The APL Paradigm and the “Co-Clinical Trial” Project

Nardella, C., Lunardi, A., Patnaik, A., Cantley, L. C., & Pandolfi, P. P. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0061 · Cited by 130 · see citing works

Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells

He, L., Zhu, H., Zhou, S., Wu, T., Wu, H., Yang, H., Mao, H., Kathera, C., Janardhan, A., Edick, A. M., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0128-8 · Cited by 125 · see citing works

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Choi, Y., Lee, S., Kim, K., Kim, S. H., Chung, Y., & Lee, C. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0115-0 · Cited by 122 · see citing works

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

Gonzalez-Exposito, R., Semiannikova, M., Griffiths, B. L., Khan, K. H., Barber, L. J., Woolston, A., Spain, G., von Loga, K., Challoner, B. R., Patel, R., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0575-3 · Cited by 121 · see citing works

The drug-induced phenotypic landscape of colorectal cancer organoids

Betge, J., Rindtorff, N., Sauer, J., Rauscher, B., Dingert, C., Gaitantzi, H., Herweck, F., Srour-Mhanna, K., Miersch, T., Valentini, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30722-9 · Cited by 121 · see citing works

A Serial Analysis of Gene Expression (SAGE) Database Analysis of Chemosensitivity

Stein, W. D., Litman, T., Fojo, T., & Bates, S. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3383 · Cited by 119 · see citing works

IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies

Zanella, E. R., Galimi, F., Sassi, F., Migliardi, G., Cottino, F., Leto, S. M., Lupo, B., Erriquez, J., Isella, C., Comoglio, P. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010445 · Cited by 117 · see citing works

A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression

Fumagalli, A., Suijkerbuijk, S. J. E., Begthel, H., Beerling, E., Oost, K. C., Snippert, H. J. G., van Rheenen, J., & Drost, J. (2018) · Nature Protocols · doi:10.1038/nprot.2017.137 · Cited by 106 · see citing works

p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo

Alexandrova, E. M., Mirza, S. A., Xu, S., Schulz‐Heddergott, R., Marchenko, N. D., & Moll, U. M. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.80 · Cited by 103 · see citing works

Long-Term Clinical Outcome of Trastuzumab and Lapatinib for HER2-Positive Metastatic Colorectal Cancer

Tosi, F., Sartore-Bianchi, A., Lonardi, S., Amatu, A., Leone, F., Ghezzi, S., Martino, C., Bencardino, K., Bonazzina, E., Bergamo, F., et al. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.06.009 · Cited by 101 · see citing works

Signal‐regulatory protein α from the NOD mouse binds human CD 47 with an exceptionally high affinity – implications for engraftment of human cells

Kwong, L. S., Brown, M. H., Barclay, A. N., & Hatherley, D. (2014) · Immunology · doi:10.1111/imm.12290 · Cited by 96 · see citing works

PI3-K/Akt pathway contributes to IL-6-dependent growth of 7TD1 cells

Zhang, J., Li, Y., & Shen, B. (2003) · Cancer Cell International · doi:10.1186/1475-2867-3-1 · Cited by 95 · see citing works

Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer

Xiong, Y., Wang, Y., & Tiruthani, K. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102034 · Cited by 88 · see citing works

Failures in Phase III: Causes and Consequences

Šeruga, B., Ocaña, A., Amir, E., & Tannock, I. F. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0124 · Cited by 88 · see citing works

A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells

Puig, I., Chicote, I., Tenbaum, S. P., Arqués, O., Herance, J. R., Gispert, J. D., Jimenez, J., Landolfi, S., Caci, K., Allende, H., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1740 · Cited by 87 · see citing works

Mouse models of colorectal cancer as preclinical models

McIntyre, R. E., Buczacki, S. J. A., Arends, M. J., & Adams, D. J. (2015) · BioEssays · doi:10.1002/bies.201500032 · Cited by 86 · see citing works

Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1

Xie, J., Xia, L., Xiang, W. D., He, W., Yin, H., Wang, F., Gao, T., Qi, W., Yang, Z., Yang, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918845117 · Cited by 84 · see citing works

Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype

Lupo, B., Sassi, F., Pinnelli, M., Galimi, F., Zanella, E. R., Vurchio, V., Migliardi, G., Gagliardi, P. A., Puliafito, A., Manganaro, D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax8313 · Cited by 83 · see citing works

Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes

Guo, G., Wang, Y., Zhou, Y., Quan, Q., Zhang, Y., Wang, H., Zhang, B., & Xia, L. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0656-3 · Cited by 81 · see citing works

Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases

Blomme, A., Simaeys, G. V., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., Lovinfosse, P., Boutry, S., Palacios, A. P., et al. (2017) · Oncogene · doi:10.1038/s41388-017-0018-x · Cited by 80 · see citing works

Primary tumour genetic alterations and intra‐tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability

Guénot, D., Guérin, É., Aguillon-Romain, S., Pencreach, E., Schneider, A., Neuville, A., Chenard, M.-P., Duluc, I., du Manoir, S., Brigand, C., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1936 · Cited by 79 · see citing works

Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy

de Almeida, C. R., Mendes, R. V., Pezzarossa, A., Gago, J., Carvalho, C. T., Alves, A., Nunes, V. M., Brito, M. J., Cardoso, M. J., Ribeiro, J. M., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1015-0 · Cited by 79 · see citing works

Cryopreservation of human colorectal carcinomas prior to xenografting

Linnebacher, M., Maletzki, C., Ostwald, C., Klier, U., Krohn, M., Klar, E., & Prall, F. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-362 · Cited by 78 · see citing works

Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patients

Cheng, C., Wang, Q., Zhu, M., Liu, K., & Zhang, Z. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0846-6 · Cited by 75 · see citing works

Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology

Sasaki, N., & Clevers, H. C. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.09.001 · Cited by 74 · see citing works

Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer

Lazzari, L., Corti, G., Picco, G., Isella, C., Montone, M., Arcella, P., Durinikova, E., Zanella, E. R., Novara, L., Barbosa, F., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3440 · Cited by 74 · see citing works

Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data

Nunes, M., Vrignaud, P., Vacher, S., Richon, S., Lièvre, A., Cacheux, W., Weiswald, L., Massonnet, G., Château‐Joubert, S., Nicolas, A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1590 · Cited by 72 · see citing works

G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist

Voloshin, T., Gingis‐Velitski, S., Bril, R., Benayoun, L., Munster, M., Milsom, C., Man, S., Kerbel, R. S., & Shaked, Y. (2011) · Blood · doi:10.1182/blood-2010-11-320812 · Cited by 68 · see citing works

Prognostic value of innate and adaptive immunity in colorectal cancer

Grizzi, F. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.174 · Cited by 67 · see citing works

In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.

Bossi, D., Cicalese, A., Dellino, G., Luzi, L., Riva, L., D'Alesio, C., Diaferia, G., Carugo, A., Cavallaro, E. C., Piccioni, R., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1200 · Cited by 67 · see citing works

Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review

Brown, K. M., Xue, A., Mittal, A., Samra, J. S., Smith, R. C., & Hugh, T. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11184 · Cited by 67 · see citing works

Modeling of Patient-Derived Xenografts in Colorectal Cancer

(2017) · doi:10.1158/1535-7163.mct-16-0721 · Cited by 64 · see citing works

Loss of heterozygosity: An independent prognostic factor of colorectal cancer

Chang, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i6.778 · Cited by 62 · see citing works

Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy

Hinze, L., Labrosse, R., Degar, J., Han, T., Schatoff, E. M., Schreek, S., Karim, S., McGuckin, C., Sacher, J. R., Wagner, F. F., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1472 · Cited by 60 · see citing works

Developments in zebrafish avatars as radiotherapy sensitivity reporters — towards personalized medicine

Costa, B. F., Ferreira, S., Póvoa, V., Cardoso, M. J., Vieira, S. C., Stroom, J. C., Fidalgo, P. O., Rio‐Tinto, R., Figueiredo, N., Parés, O., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.039 · Cited by 58 · see citing works

Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties

Nakayama, M., Hong, C. P., Oshima, H., Sakai, E., Kim, S., & Oshima, M. (2020) · Nature Communications · doi:10.1038/s41467-020-16245-1 · Cited by 56 · see citing works

Colorectal cancer patient–derived xenografted tumors maintain characteristic features of the original tumors

Cho, Y. B., Hong, H. K., Choi, Y., Oh, E., Joo, K. M., Jin, J., Nam, D., Ko, Y. H., & Lee, W. Y. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.11.010 · Cited by 56 · see citing works

Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer

Xie, B., & Wu, A. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.191782 · Cited by 55 · see citing works

Chimeric Antigen Receptor–modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model

Teng, R., Zhao, J., Zhao, Y., Gao, J., Li, H., Zhou, S., Wang, Y., Sun, Q., Lin, Z., Yang, W., et al. (2018) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000251 · Cited by 53 · see citing works

The role of mouse models in colorectal cancer research—The need and the importance of the orthotopic models

Oliveira, R. C., Abrantes, A. M., Tralhão, J. G., & Botelho, M. F. (2020) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12102 · Cited by 50 · see citing works

Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics

Hulton, C. H., Costa, E. A., Shah, N., Quintanal-Villalonga, À., Heller, G., de Stanchina, E., Rudin, C. M., & Poirier, J. T. (2020) · Nature Cancer · doi:10.1038/s43018-020-0040-8 · Cited by 47 · see citing works

Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells

Hasgur, S., Aryee, K., Shultz, L. D., Greiner, D. L., & Brehm, M. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3661-8_4 · Cited by 47 · see citing works

Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research

Inoue, A., Deem, A. K., Kopetz, S., Heffernan, T. P., Draetta, G. F., & Carugo, A. (2019) · Cancers · doi:10.3390/cancers11091321 · Cited by 46 · see citing works

The Use of Matrigel to Facilitate the Establishment of Human Cancer Cell Lines as Xenografts

Mullen, P. (2003) · Humana Press eBooks · doi:10.1385/1-59259-406-9:287 · Cited by 45 · see citing works

Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations

Yao, Y.-M., Donoho, G. P., Iversen, P. W., Zhang, Y., Horn, R. D. V., Forest, A., Novosiadly, R. D., Webster, Y., Ebert, P. J., Bray, S. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3250 · Cited by 44 · see citing works

Capturing colorectal cancer inter‐tumor heterogeneity in patient‐derived xenograft (PDX) models

Prasetyanti, P. R., van Hooff, S. R., van Herwaarden, T., de Vries, N., Kalloe, K., Rodermond, H. M., van Leersum, R., de Jong, J. H., Franitza, M., Nürnberg, P., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31767 · Cited by 43 · see citing works

Modeling rectal cancer to advance neoadjuvant precision therapy

Janakiraman, H., Zhu, Y., Becker, S. A., Wang, C., Cross, A. W., Curl, E., Lewin, D., Hoffman, B. J., Warren, G. W., Hill, E. G., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32876 · Cited by 40 · see citing works

Human colorectal cancer-derived carcinoma associated fibroblasts promote CD44-mediated adhesion of colorectal cancer cells to endothelial cells by secretion of HGF

Zhang, R., Qi, F., Shao, S., Li, G., & Feng, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0914-y · Cited by 39 · see citing works

Patient-derived Xenografts from Colorectal Carcinoma: A Temporal and Hierarchical Study of Murine Stromal Cell Replacement

Chao, C., Widen, S. G., Wood, T. G., Zatarain, J. R., Johnson, P. R., Gajjar, A. H., GOMEZ, G., Qiu, S., Thompson, J. C., Spratt, H. M., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11707 · Cited by 39 · see citing works

Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient–Derived Xenografts

Suhaimi, N.-A. M., Phyo, W. M., Yap, H. Y., Choy, S. H. Y., Wei, X., Choudhury, Y., Tan, W. J., Tan, L. A. P. Y., Foo, R., Tan, S. H. S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0793 · Cited by 33 · see citing works

Establishment of genetically diverse patient-derived xenografts of colorectal cancer.

Burgenske, D. M., Monsma, D. J., Dylewski, D., Scott, S. B., Sayfie, A. D., Kim, D. G., Luchtefeld, M. A., Martin, K. R., Stephenson, P. L., III, Hostetter, G. H., et al. (2014) · Europe PMC (PubMed Central) · Cited by 32 · see citing works

Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models

Gock, M. C., Kühn, F., Mullins, C. S., Krohn, M., Prall, F., Klar, E., & Linnebacher, M. (2016) · BioMed Research International · doi:10.1155/2016/1715053 · Cited by 31 · see citing works

Human Regulatory T Cells Do Not Suppress the Antitumor Immunity in the Bone Marrow: A Role for Bone Marrow Stromal Cells in Neutralizing Regulatory T Cells

Guichelaar, T., Emmelot, M. E., Rozemuller, H., Martini, B., Groen, R. W. J., Storm, G., Lokhorst, H. M., Martens, A. C., & Mutis, T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2177 · Cited by 28 · see citing works

Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga

Catalano, I., Grassi, E., Bertotti, A., & Trusolino, L. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.10.006 · Cited by 27 · see citing works

Genetically Engineered Human Cancer Models Utilizing Mammalian Transgene Expression

Kendall, S., Adam, S. J., & Counter, C. M. (2006) · Cell Cycle · doi:10.4161/cc.5.10.2734 · Cited by 25 · see citing works

Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts

Cybulska, M., Olesiński, T., Goryca, K., Paczkowska, K., Statkiewicz, M., Kopczyński, M., Grochowska, A., Unrug-Bielawska, K., Tyl-Bielicka, A., Gajewska, M. E., et al. (2018) · BioMed Research International · doi:10.1155/2018/2954208 · Cited by 24 · see citing works

Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs

Naruse, M., Ochiai, M., Sekine, S., Taniguchi, H., Yoshida, T., Ichikawa, H., Sakamoto, H., Kubo, T., Matsumoto, K., Ochiai, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81475-2 · Cited by 24 · see citing works

Genomic Profiling of Patient-Derived Colon Cancer Xenograft Models

Lee, W., Kim, H.-Y., Seok, J. Y., Jang, H. H., Park, Y. H., Kim, S., Shin, D. B., & Hong, S. (2014) · Medicine · doi:10.1097/md.0000000000000298 · Cited by 24 · see citing works

Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies

Visioli, A., Giani, F., Trivieri, N., Pracella, R., Miccinilli, E., Cariglia, M. G., Palumbo, O., Arleo, A., Dezi, F., Copetti, M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.049 · Cited by 21 · see citing works

Establishing metastatic patient-derived xenograft model for colorectal cancer

Zhang, Y., Lee, S. H., Wang, C., Gao, Y., Li, J., & Xu, W. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa089 · Cited by 20 · see citing works

Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer

Altunel, E., Roghani, R. S., Chen, K., Kim, S. Y., McCall, S. J., Ware, K. E., Shen, X., Somarelli, J. A., & Hsu, D. S. (2020) · BMC Cancer · doi:10.1186/s12885-020-07090-y · Cited by 17 · see citing works

Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF Variants

Post, J. B., Roodhart, J. M. L., & Snippert, H. J. G. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.12.005 · Cited by 16 · see citing works

The drug-induced phenotypic landscape of colorectal cancer organoidsPreprint

Betge, J., Rindtorff, N., Sauer, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/660993 · Cited by 16 · see citing works

Development of patient-derived orthotopic xenografts from metastatic colorectal cancer in nude mice

Roque-Lima, B., Roque, C. A., Begnami, M. D., Peresi, P. M., Lima, E. N. P., de Mello, C. A. L., Coimbra, F. J. F., Chojniak, R., & Santos, T. G. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1509983 · Cited by 9 · see citing works

Establishing a colorectal cancer liver metastasis patient-derived tumor xenograft model for the evaluation of personalized chemotherapy

Jung, J., Kim, J., Lim, H. K., Kim, K. M., Lee, Y. S., Park, J. S., & Yoon, D. S. (2017) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2017.93.4.173 · Cited by 8 · see citing works

Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab

Zhang, H., Yuan, L., Liu, L., Yan, C., Cheng, J., Fu, Q., Tong, Z., Jiang, W., Zheng, Y., Zhao, P., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06909-y · Cited by 7 · see citing works

Stemness Underpinning All Steps of Human Colorectal Cancer Defines the Core of Effective Therapeutic StrategiesPreprint

Vescovi, L. A., Giani, F., Trivier, N., Miccinilli, E., Pracella, R., Palumbo, O., Cariglia, M. G., Arleo, A., Dezi, F., Copetti, M., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3304251 · Cited by 2 · see citing works

Abstract 3919: Liquid biopsy derived organoids as a potential platform for personalized cancer therapy in metastatic prostate cancer

Mout, L., van Dessel, L. F., Kraan, J., de Jong, A. C., Neves, R. P., Erkens‐Schulze, S., Siewerts, A. M., van Riet, J., de Wit, R., Sleijfer, S., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-3919 · Cited by 1 · see citing works

Patient-derived xenograft models in cancer therapy: technologies and applications

Liu, Y., Wu, W., Cai, C., Zhang, H., Shen, H., & Han, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01419-2 · Cited by 524 · see citing works

Targeting PI3K/AKT/mTOR signaling to overcome drug resistance in cancer

Tufail, M., Wan, W., Jiang, C., & Li, N. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111055 · Cited by 68 · see citing works

Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer

Jin, J., Wu, Y., Zhao, Z., Wu, Y., Zhou, Y.-D., Liu, S., Sun, Q., Yang, G., Lin, J., Nagle, D. G., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160606 · Cited by 57 · see citing works

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 53 · see citing works

Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms—Challenges and Opportunities for Translational Precision Oncology

Al-Kabani, A., Huda, B., Haddad, J., Yousuf, M., Bhurka, F., Ajaz, F., Patnaik, R., Jannati, S., & Banerjee, Y. (2025) · Cancers · doi:10.3390/cancers17132163 · Cited by 44 · see citing works

Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models

Ringquist, R., Ghoshal, D., Jain, R., & Roy, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114003 · Cited by 39 · see citing works

Exploring the integration of nanotechnology in the development and application of biosensors for enhanced detection and monitoring of colorectal cancer

Hajjafari, A., Sadr, S., Rahdar, A., Bayat, M., Lotfalizadeh, N., Dianaty, S., Rezaei, A., Moghaddam, S. P., Hajjafari, K., Simab, P. A., et al. (2024) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2024.112409 · Cited by 35 · see citing works

Epithelial–mesenchymal transition to mitigate age-related progression in lung cancer

Thapa, R., Gupta, S., Gupta, G., Bhat, A. A., Smriti, Smriti, Ali, H., Singh, S. K., Dua, K., & Kashyap, M. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102576 · Cited by 34 · see citing works

The Orexin receptors: Structural and anti-tumoral properties

Couvineau, A., Nicole, P., Gratio, V., & Voisin, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931970 · Cited by 30 · see citing works

Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer

Wu, F., Chen, P.-M., Gardinier, T. C., Turker, M. Z., Venkatesan, A. M., Patel, V., Khor, T. O., Bradbury, M. S., Wiesner, U. B., Adams, G. P., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05342 · Cited by 30 · see citing works

Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective

Puccini, A., Seeber, A., & Berger, M. D. (2022) · Cancers · doi:10.3390/cancers14194828 · Cited by 30 · see citing works

Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target

Couvineau, A., Nicole, P., Gratio, V., & Voisin, T. (2021) · Molecules · doi:10.3390/molecules26164849 · Cited by 28 · see citing works

Self-assembled PROTACs enable protein degradation to reprogram the tumor microenvironment for synergistically enhanced colorectal cancer immunotherapy

Lu, X., Jin, J., Wu, Y., Lin, J., Zhang, X., Lu, S., Zhang, J., Zhang, C., Ren, M., Chen, H., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.09.022 · Cited by 27 · see citing works

The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems

Foglietta, F., Serpe, L., & Canaparo, R. (2021) · Cells · doi:10.3390/cells10123295 · Cited by 27 · see citing works

Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review

Tanaka, T., Nishie, R., Ueda, S., Miyamoto, S., Hashida, S., Konishi, H., Terada, S., Kogata, Y., Sasaki, H., Tsunetoh, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179369 · Cited by 25 · see citing works

Generation of Antibody-Drug Conjugate Resistant Models

Gandullo‐Sánchez, L., Ocaña, A., & Pandiella, A. (2021) · Cancers · doi:10.3390/cancers13184631 · Cited by 22 · see citing works

Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient‐Derived Tissue Laden Tissue‐Specific Bioink

Choi, Y., Na, D., Yoon, G., Kim, J., Min, S., Yi, H., Cho, S., Cho, J. H., Lee, C., & Jang, J. (2025) · Advanced Science · doi:10.1002/advs.202411769 · Cited by 21 · see citing works

Patient‐derived xenograft model in colorectal cancer basic and translational research

Liu, X., Xin, Z., & Wang, K. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12299 · Cited by 21 · see citing works

Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer

Iyer, K. K., van Erp, N. P., Tauriello, D. V. F., Verheul, H. M. W., & Poel, D. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102466 · Cited by 20 · see citing works

Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer

Jiang, H., Zhou, S., & Li, G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1189799 · Cited by 15 · see citing works

The HROC-Xenobank—A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models

Matschos, S., Bürtin, F., Kdimati, S., Radefeldt, M., Krake, S., Prall, F., Engel, N., Krohn, M., Micheel, B., Kreutzer, M., et al. (2021) · Cancers · doi:10.3390/cancers13235882 · Cited by 14 · see citing works

Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches

Fatemi, N., Mirbahari, S. N., Tierling, S., Sanjabi, F., Shahrivari, S., AmeliMojarad, M., AmeliMojarad, M., Rezaei, M. M., Nobaveh, P., Totonchi, M., et al. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08774-2 · Cited by 13 · see citing works

A perfused multi-well bioreactor platform to assess tumor organoid response to a chemotherapeutic gradient

Wasson, E. M., He, W., Ahlquist, J., Hynes, W. F., Triplett, M., Hinckley, A., Karelehto, E., Gray-Scherr, D., Friedman, C. F., Robertson, C., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1193430 · Cited by 9 · see citing works

Selection and Optimization of a Bioink Based on PANC-1- Plasma/Alginate/Methylcellulose for Pancreatic Tumour Modelling

Sánchez, C. B., Mateo, N. C., Saldaña, L., Valdivieso, A., Earl, J., González, I., & Rodríguez-Lorenzo, L. M. (2023) · Polymers · doi:10.3390/polym15153196 · Cited by 9 · see citing works

CONNECTOR, fitting and clustering of longitudinal data to reveal a new risk stratification system

Pernice, S., Sirovich, R., Grassi, E., Viviani, M., Ferri, M., Sassi, F. P., Alessandrì, L., Tortarolo, D., Calogero, R., Trusolino, L., et al. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad201 · Cited by 9 · see citing works

Transwell-Hypoxia Method Facilitates the Outgrowth of 3D-Printed Collagen Scaffolds Loaded with Cryopreserved Patient-Derived Melanoma Explants

Park, M., Bang, C. H., Yun, W., Jin, S., & Jeong, Y. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00710 · Cited by 7 · see citing works

Recapitulating Tumor Microenvironment Using AXTEX-4DTM for Accelerating Cancer Research and Drug Screening

Baru, A., Mazumdar, S., Kundu, P., Sharma, S., Purakayastha, B. P. D., Khan, S., Gupta, R., & Arora, N. M. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.2.561 · Cited by 6 · see citing works

The utility of 3D models to study cholesterol in cancer: Insights and future perspectives

du Plessis, T.-L., Abdulla, N., & Kaur, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1156246 · Cited by 6 · see citing works

Exploring novel strategies of oncolytic viruses and gut microbiota to enhance CAR-T cell therapy for colorectal cancer

Yi, J., Quji, S., Guo, L., Chai, Z., Kong, X., & Meng, J. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.105026 · Cited by 6 · see citing works

Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy

Alkhilaiwi, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.761986 · Cited by 6 · see citing works

DLL1-responsive PD-L1 + tumor-associated macrophages promote endocrine resistance in breast cancer

Singh, S., Weindorfer, C., Nandi, A., Selvam, C. P., Götze, M. M., Das, M., Falaschini, A., Tjendra, Y., Boone, M., Dolznig, H., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adr6207 · Cited by 5 · see citing works

Molecular mechanisms of astragaloside-IV in hepatocellular carcinoma therapy: a systematic review

Gao, X. Y., Hao, W., Wang, Y., Wu, X., Zhu, F., & Zhang, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-14758-w · Cited by 5 · see citing works

Establishment of 6 pediatric rhabdomyosarcoma patient’s derived xenograft models closely recapitulating patients’ tumor characteristics

Gasparini, P., Casanova, M., Centonze, G., Borzi, C., Bergamaschi, L., Collini, P., Testi, A., Chiaravalli, S., Massimino, M., Sozzi, G., et al. (2022) · Tumori Journal · doi:10.1177/03008916221110266 · Cited by 5 · see citing works

A comprehensive review of microfluidic-based organ-on-chip technology in the application of preclinical drug discovery studies

Shetty, S., Kumar, N. A. N., Kabekkodu, S. P., & Chakrabarty, S. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189627 · Cited by 4 · see citing works

Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models

Tang, Y.-C., Ou, J., Hsu, S.-C., Huang, C., Lin, L.-M., Chang, H.-H., Wang, Y.-H., Huang, Z.-T., Sun, M., Liu, K.-J., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107556 · Cited by 5 · see citing works

Optimal Treatment for Drug-Induced Cancer Persisters Involves Release Periods and Intermediate Drug Doses

Corigliano, M., Bernardo, A. D., Lagomarsino, M. C., & Pompei, S. (2025) · PRX Life · doi:10.1103/mh5v-lcyw · Cited by 4 · see citing works

The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years

McCall, S. J., Lubensky, I. A., Moskaluk, C. A., Parwani, A. V., Radin, K., Ramirez, N. C., von Menchhofen, Z., Washington, M. K., & LiVolsi, V. A. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0714 · Cited by 4 · see citing works

Targeting the DNA damage response prevents regrowth of colorectal peritoneal metastasis-derived organoids following treatment with mitomycin C

van Megesen, K., Stefan, A., Kieboom, M. M., Amico, R., Jansen, A. M. L., Rinkes, I. H. M. B., & Kranenburg, O. (2026) · British Journal of Cancer · doi:10.1038/s41416-025-03310-z · Cited by 2 · see citing works

Preclinical In Vivo Animal Xenograft Models: Heterogeneity and Biomarkers of Therapeutic Response and Resistance

Zaky, M. Y., Lamloum, N. S., Ahmed, N. A., & Ahmed, O. M. (2025) · Springer eBooks · doi:10.1007/978-981-97-5742-8_5 · Cited by 2 · see citing works

Experimental toolkit to study the oncogenic role of WNT signaling in colorectal cancer

Dash, P., Yadav, V. K., Das, B., & Satapathy, S. R. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189354 · Cited by 2 · see citing works

Kaempferol as a potent sensitizer for 5-fluorouracil (5-FU) to boost therapeutic index in colorectal cancer therapy

Sharma, A., Thakur, A., Chorawala, M. R., Rawal, R., & Shrivastava, N. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106973 · Cited by 2 · see citing works

Chinese expert consensus on precision diagnosis and treatment of refractory tumors

Wang, L., Zhang, Y., Shang, Y., Lu, Y., Hu, H., Wang, G., & Wang, H. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105109 · Cited by 1 · see citing works

Efficacy of dual KRASG12D–EGFR blockade versus triple combinations in patient-derived models of KRASG12D-mutant colorectal cancer

Leto, S. M., Sassi, F. P., Zanella, E. R., Vurchio, V., Cottino, F., Ferri, M., Damico, A., Grassi, E., Bertotti, A., & Trusolino, L. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08900-0 · Cited by 1 · see citing works

Nanomedicine-Based Therapeutic Approaches in Colorectal Cancer Using Patient-Derived Xenograft Models: Prospects and Challenges

Wang, X., Xiao, J., Yang, Y., & Li, T. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s573763 · Cited by 1 · see citing works

Preclinical Models in Colorectal Cancer Drug Discovery

Yang, Y., Meng, W., & Wang, Z. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_56 · Cited by 1 · see citing works

Preclinical Models in Colorectal Cancer Drug Discovery

Yang, Y., Meng, W., & Wang, Z. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_56-1

SWIFT DIAGNOSIS OF COLORECTAL CANCER AND MITIGATION BY PHYTOMOLECLES: AN EXPERIMENTAL STUDY

Gupta, A., Mondal, S., Pradhan, S., Hansda, R., Datta, S., & Sarkar, G. (2022) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/9706194

High Content Imaging Applications of Advanced and Translational Disease Models in Drug Discovery and Development

Cui, W., Haffa, M., Massai, F., Qian, K., Vallin, M., Axelsson, H., & Seashore-Ludlow, B. A. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837676941-00168

Establishment of humanized patient-derived xenografts (PDXs) from primary human colorectal cancer tumors

Navarrete‐Sirvent, C., Rivas‐Crespo, A., Sánchez-Montero, M. T., Díaz‐Chacón, A., Peña-Enríquez, R., Aranda, E., Rodríguez‐Ariza, A., & Guil‐Luna, S. (2026) · Methods in cell biology · doi:10.1016/bs.mcb.2026.01.001

A microscopically assisted limited colectomy mouse model of early colon cancer

Han, Y., Zhang, Y., Gao, D., & Zhao, X. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70175

Spatial Association Between Polyamine Metabolism and Lipid Peroxidation in Different Pathological Regions of Glioblastoma

Qu, Z., Guo, K., Xiang, X., An, Y., Lei, T., Liu, A., Wang, Y., Chen, D., Chen, H., Zhang, Z., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14092067

Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma

Ramzy, G. M., Koessler, T., Ducrey, E., McKee, T., Ris, F., Buchs, N. C., Rubbia‐Brandt, L., Dietrich, P., & Nowak-Sliwinska, P. M. (2020) · Cancers · doi:10.3390/cancers12061423 · Cited by 42 · see citing works

Development of Preclinical Models to Understand and Treat Colorectal Cancer

Sebolt, J. S. (2018) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0037-1602240 · Cited by 12 · see citing works

Advanced Colorectal Cancer Orthotopic Patient-Derived Xenograft Models for Cancer and Stem Cell Research

Chicote, I., Cámara, J. A., & Pálmer, H. G. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0747-3_22 · Cited by 5 · see citing works

Mouse models of colorectal cancer: Past, present and future perspectives

Bürtin, F., Mullins, C. S., & Linnebacher, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i13.1394 · Cited by 169 · see citing works

Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges

Durinikova, E., Buzo, K., & Arena, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01981-z · Cited by 60 · see citing works